Qualifyze: Funding, Investors & Team (Sep 2026)
Qualifyze provides support to pharmaceutical companies by offering quick, adaptable, and trustworthy assessments of supply chain compliance. Through their data and application platform, Qualifyze connects clients, suppliers, and auditors, transforming audit data into valuable insights on supplier compliance. This helps healthcare partners monitor and predict quality and sustainability compliance efforts. By accessing supplier compliance information anytime and across multiple sites on their cloud-based platform, customers can streamline and optimize supplier risk mitigation processes. With a global network of expert auditors, numerous pharma clients, and a vast database of supplier compliance data, Qualifyze is a key provider of structured and analyzable audit data in the pharmaceutical supply chain.
Qualifyze has raised $54.0M across 1 funding round on record, the most recent a Series B of $54.0M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Qualifyze Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Qualifyze Funding Rounds
Qualifyze Founders and Leadership Team
Contact details for the Qualifyze team: 1 of 1 has an email address on file.
Start 14-day free trial →Qualifyze Funding Compared to Other Biotechnology Startups
Qualifyze's latest round of $54.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Qualifyze in Biotechnology and Frankfurt
Companies Similar to Qualifyze
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Qualifyze Funding FAQs
What does Qualifyze do?
Qualifyze provides support to pharmaceutical companies by offering quick, adaptable, and trustworthy assessments of supply chain compliance. Through their data and application platform, Qualifyze connects clients, suppliers, and auditors, transforming audit data into valuable insights on supplier compliance. This helps healthcare partners monitor and predict quality and sustainability compliance efforts. By accessing supplier compliance information anytime and across multiple sites on their cloud-based platform, customers can streamline and optimize supplier risk mitigation processes. With a global network of expert auditors, numerous pharma clients, and a vast database of supplier compliance data, Qualifyze is a key provider of structured and analyzable audit data in the pharmaceutical supply chain.
How much funding has Qualifyze raised?
Qualifyze has raised $54.0M across 1 round on record. The most recent is a Series B of $54.0M announced in Sep 2024.
When did Qualifyze last raise funding?
Qualifyze's most recent funding round on record is a Series B of $54.0M, announced in Sep 2024.
Who founded Qualifyze?
FundedIQ lists David Schneider (Founder) at Qualifyze.
Where is Qualifyze headquartered?
Qualifyze is based in Frankfurt, Hessen, Germany.
How many employees does Qualifyze have?
Qualifyze is in the 101-250 employee band.
How does Qualifyze's funding compare to other Biotechnology startups?
Qualifyze's latest round of $54.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Qualifyze Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Qualifyze is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.